Fibrillary glomerulonephritis: An apparent familial form?

Fibrillary glomerulonephritis is a rare cause of glomerulonephritis characterized by non‐amyloid fibrillary deposits of unknown aetiology. It is generally considered idiopathic but may be associated with secondary causes such as monoclonal gammopathy, hepatitis B and C infections, autoimmune disease...

Full description

Saved in:
Bibliographic Details
Published inNephrology (Carlton, Vic.) Vol. 20; no. 7; pp. 506 - 509
Main Authors Ying, Tracey, Hill, Prue, Desmond, Michael, Agar, John, Mallett, Andrew
Format Journal Article
LanguageEnglish
Published Australia Blackwell Publishing Ltd 01.07.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Fibrillary glomerulonephritis is a rare cause of glomerulonephritis characterized by non‐amyloid fibrillary deposits of unknown aetiology. It is generally considered idiopathic but may be associated with secondary causes such as monoclonal gammopathy, hepatitis B and C infections, autoimmune diseases and malignancies. We report two Australian families with apparent familial fibrillary glomerulonephritis inherited in an autosomal dominant pattern, and postulate the existence of a primary familial entity. Family 1 consists of an affected father and daughter; the daughter progressed to end‐stage renal failure within 18 months of diagnosis, despite immunosuppressive therapy. The father, however, remains stable at 10 months follow up. Family 2 comprises an affected mother and son; the mother commenced haemodialysis 5 years after diagnosis and subsequently underwent successful renal transplantation. The son is presently stable at last follow‐up after 5 years. A further review of the second family history reveals a third family member (maternal father) dying of ‘Bright's disease’. We describe their histopathology, clinical progression and treatment outcomes, and provide a review of the current understanding of this heterogeneous condition that is associated with poor renal outcomes.
Bibliography:ark:/67375/WNG-0B924PF0-0
Amgen
Genzyme
istex:E043EC42000B951FB2DCC59A9CB51BB622D9B805
ArticleID:NEP12447
ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:1320-5358
1440-1797
DOI:10.1111/nep.12447